The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Carcinoma, Bronchogenic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Carcinoma, Bronchogenic


Psychiatry related information on Carcinoma, Bronchogenic


High impact information on Carcinoma, Bronchogenic


Chemical compound and disease context of Carcinoma, Bronchogenic


Biological context of Carcinoma, Bronchogenic


Anatomical context of Carcinoma, Bronchogenic


Gene context of Carcinoma, Bronchogenic


Analytical, diagnostic and therapeutic context of Carcinoma, Bronchogenic


  1. Ectopic and eutopic secretion of chorionic gonadotropin and its sub-nits in vitro: comparison of clonal strains from carcinomas of lung and placenta. Lieblich, J.M., Weintraub, B.D., Krauth, G.H., Kohler, P.O., Rabson, A.S., Rosen, S.W. J. Natl. Cancer Inst. (1976) [Pubmed]
  2. Steroid receptors in human lung cancer. Beattie, C.W., Hansen, N.W., Thomas, P.A. Cancer Res. (1985) [Pubmed]
  3. VP-16-213 (etoposide): the mandrake root from Issyk-Kul. Vogelzang, N.J., Raghavan, D., Kennedy, B.J. Am. J. Med. (1982) [Pubmed]
  4. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma. Samaan, N.A., Castillo, S., Schultz, P.N., Khalil, K.G., Johnston, D.A. J. Clin. Endocrinol. Metab. (1980) [Pubmed]
  5. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Patz, E.F., Lowe, V.J., Hoffman, J.M., Paine, S.S., Harris, L.K., Goodman, P.C. Radiology. (1994) [Pubmed]
  6. The therapeutic response of three human tumor lines maintained in immune-suppressed mice. Kopper, L., Steel, G.G. Cancer Res. (1975) [Pubmed]
  7. The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy. Lyman, G.H., Williams, C.C., Preston, D. N. Engl. J. Med. (1980) [Pubmed]
  8. Atypical plasma factor associated with bronchogenic carcinoma and complexing with R-type vitamin B12-binding proteins. Jacob, E., Herbert, V., Burger, R.L., Allen, R.H. N. Engl. J. Med. (1977) [Pubmed]
  9. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Ayesh, R., Idle, J.R., Ritchie, J.C., Crothers, M.J., Hetzel, M.R. Nature (1984) [Pubmed]
  10. Autonomic neuropathy and inappropriate secretion of antidiuretic hormone. Occurrence in a patient with bronchogenic carcinoma. Carr-Locke, D.L. JAMA (1979) [Pubmed]
  11. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP). Bitran, J.D., Desser, R.K., DeMeester, T., Golomb, H.M. JAMA (1978) [Pubmed]
  12. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine. Chahinian, P.A., Arnold, D.J., Cohen, J.M., Purpora, D.P., Jaffrey, I.S., Teirstein, A.S., Kirschner, P.A., Holland, J.F. JAMA (1977) [Pubmed]
  13. Combination chemotherapy and radiation therapy for small cell carcinoma. Holoye, P.Y., Samuels, M.L., Lanzotti, V.J., Smith, T., Barkley, H.T. JAMA (1977) [Pubmed]
  14. Perhexilene mimicking bronchial carcinoma. Dawkins, K.D., O'Connor, E. Lancet (1978) [Pubmed]
  15. Mechanism of benzo(a)pyrene induction of alpha-human chorionic gonadotropin gene expression in human lung tumor cells. Wong, D.T., Biswas, D.K. J. Cell Biol. (1985) [Pubmed]
  16. Normal bronchial epithelial cell expression of glutathione transferase P1, glutathione transferase M3, and glutathione peroxidase is low in subjects with bronchogenic carcinoma. Crawford, E.L., Khuder, S.A., Durham, S.J., Frampton, M., Utell, M., Thilly, W.G., Weaver, D.A., Ferencak, W.J., Jennings, C.A., Hammersley, J.R., Olson, D.A., Willey, J.C. Cancer Res. (2000) [Pubmed]
  17. Lung cancer and mutations at the polymorphic NAT2 gene locus. Martínez, C., Agúndez, J.A., Olivera, M., Martín, R., Ladero, J.M., Benítez, J. Pharmacogenetics (1995) [Pubmed]
  18. Relationship between myelosuppression and chemotherapeutic response in small cell bronchogenic carcinoma. Holoye, P.Y. Exp. Hematol. (1985) [Pubmed]
  19. Correlation of expression of binding sites for synthetic blood group A-, B- and H-trisaccharides and for sarcolectin with survival of patients with bronchial carcinoma. Kayser, K., Bovin, N.V., Korchagina, E.Y., Zeilinger, C., Zeng, F.Y., Gabius, H.J. Eur. J. Cancer (1994) [Pubmed]
  20. Bioavailability of ifosfamide in patients with bronchial carcinoma. Cerny, T., Margison, J.M., Thatcher, N., Wilkinson, P.M. Cancer Chemother. Pharmacol. (1986) [Pubmed]
  21. An endothelial cell growth factor derived from human lung carcinoma cells grown in serum-free medium. Walker, C., Mates, G., Pumford, D., Daniel, M. J. Cell. Sci. (1987) [Pubmed]
  22. Autoantibodies in patients with bronchial carcinoma. Hodson, M.E., Turner-Warwick, M. Thorax (1975) [Pubmed]
  23. Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma. DiBella, N.J., Nelson, R.A., Norgard, M.J. Oncology (1975) [Pubmed]
  24. Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma. Eck, H.P., Drings, P., Dröge, W. J. Cancer Res. Clin. Oncol. (1989) [Pubmed]
  25. Axillary lymph node metastases from bronchogenic carcinoma. Riquet, M., Le Pimpec-Barthes, F., Danel, C. Ann. Thorac. Surg. (1998) [Pubmed]
  26. Production of interleukin-10 by human bronchogenic carcinoma. Smith, D.R., Kunkel, S.L., Burdick, M.D., Wilke, C.A., Orringer, M.B., Whyte, R.I., Strieter, R.M. Am. J. Pathol. (1994) [Pubmed]
  27. A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bronchogenic carcinoma. Gorgoulis, V.G., Zoumpourlis, V., Rassidakis, G.Z., Karameris, A., Rassidakis, A.N., Spandidos, D.A., Kittas, C. J. Pathol. (1996) [Pubmed]
  28. Co-expression of Cox-2 and EGFR in stage I human bronchial adenocarcinomas. Araki, K., Hashimoto, K., Ardyanto, T.D., Osaki, M., Shomori, K., Nakamura, H., Ito, H. Lung Cancer (2004) [Pubmed]
  29. Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B study. Green, M., Horton, C., Spaulding, M., Silver, R.T., Berenberg, J., Kennedy, B.J., Pajak, T.F., Comis, R. J. Clin. Oncol. (1983) [Pubmed]
  30. Human papillomavirus infection is not associated with bronchial carcinoma: evaluation by in situ hybridization and the polymerase chain reaction. Welt, A., Hummel, M., Niedobitek, G., Stein, H. J. Pathol. (1997) [Pubmed]
  31. Staging non-small cell lung cancer with whole-body PET. Marom, E.M., McAdams, H.P., Erasmus, J.J., Goodman, P.C., Culhane, D.K., Coleman, R.E., Herndon, J.E., Patz, E.F. Radiology. (1999) [Pubmed]
  32. Low serum testosterone as an indicator of metastatic bronchial carcinoma. Taggart, D.P., Gray, C., Davidson, K.G., Faichney, A. Thorax (1987) [Pubmed]
  33. 75Se-sodium selenite as a diagnostic aid in the assessment of peripheral pulmonary opacities. Whitton, I.D., Houlder, A.E. Thorax (1979) [Pubmed]
WikiGenes - Universities